Aug 16, 2023 · Moderna and Merck opted to kick off their joint clinical program in melanoma, as this cancer is known to be immunogenic and to respond to checkpoint inhibitors.

The 2025–2026 COVID-19 vaccine is safe and recommended for people who have cancer or have been treated for it. COVID-19 has become less of a threat for some people.

Jan 6, 2026 · This absence of evaluation of COVID19 vaccines for carcinogenicity or genotoxicity motivated a systematic review and synthesis of the available evidence from 2020–2025 …

1 day ago · Moderna expects long-term data in early 2026 from a mid-stage melanoma trial of its personalised cancer vaccine developed with Merck, followed by possible Phase 3 results later …

Apr 1, 2024 · People with blood cancer have increased risk of severe COVID-19 outcomes and poor response to vaccination. We assessed the safety and effectiveness of…

Apr 1, 2025 · Moderna’s mRNA-based cancer vaccine has demonstrated a 75% reduction in recurrence for melanoma and lung cancer, marking a potential shift in oncology treatment. …

This page answers questions about COVID-19 vaccines and cancer and how the vaccines may affect cancer treatment.

8 hours ago · Moderna's in-house developed vaccine, mRNA-4359, encodes two epitopes, PD-L1 and IDO1, which cancer cells exploit to escape immune recognition, and is designed to evoke …

Dec 13, 2022 · This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including regarding: the …

Feb 27, 2024 · An international study of around 99 million people confirmed known serious side effects of COVID-19 vaccination. It also identified a possible relationship between the first …